TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project January 29, 2010